Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mizoribine plus dipyridamole versus benazepril plus dipyridamole in pediatric IgA nephropathy
ChiCTR-TRC-13003038Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of mizoribine in IgA nephropathy (IgAN) (2 arms), sponsored by Peking University First Hospital. Primary endpoints: 24-hour urinary protein, urinary protein-creatinine ratio and 1 more. Started Jan 2013; status: completed.
02
Drugs
mizoribine
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on ChiCTR-TRC-13003038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003038.